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Background: Helicobacter pylori infection that is usually acquired in childhood and lasts for lifetime is mostly
asymptomatic but associated with severe gastrointestinal disease including cancer. During chronic infection, the
gastric mucosa is histologically changing. This forces H. pylori to permanent adaptation in its gastric habitat by
expression of different proteins which might be reflected in distinctive antibody patterns.
Methods: To characterize dynamics of the immune response to H. pylori we analysed 1797 sera of a cross-sectional
study representative for the German population (age range 1–82 years) with multiplex serology, a fluorescent bead-based
antibody binding assay that allows simultaneous and quantitative detection of antibodies. Fifteen recombinant,
affinity-purified H. pylori proteins (UreA, GroEL, Catalase, NapA, CagA, CagM, Cagδ, HP0231, VacA, HpaA, Cad,
HyuA, Omp, HcpC and HP0305) were used as antigens.
Results: H. pylori seroprevalence (positivity for at least three antigens) was 48% and increased with age from
12% in children <15 years to 69% in females and 90% in males >65 years. Prevalences were highest (>83%) for
Omp, VacA and GroEL. For 11 proteins, seroprevalence was higher in males than females (P < 0.05) from age 55
onwards. For all antigens, the median prevalence increase per age decade was stronger in males (8.4%, range
3.8-12.9%) than females (6.1%, range 3.4-10.8%). However, among seropositives the median number of antigens
recognized increased from children <15 years to individuals >65 years stronger in females (P = 0.02). Antibody
reactivities to GroEL, HyuA, CagM, Catalase, NapA and UreA also increased stronger in females (average 1.7-fold/
decade, SD 0.5) than in males (1.5-fold/decade, SD 0.4).
Conclusion: H. pylori antibody response accumulates qualitatively and quantitatively with age. This may reflect a
lifelong stimulation of the immune response by chronically active infection.
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More than half the world’s middle-aged population is
infected with the gram-negative bacterium Helicobacter
pylori. Overall estimate of prevalence of infection is 78%
in developing and 58% in developed countries [1]. Preva-
lence of infection steadily declines in the industrialized
Western World and emerging economies [2]. The bacter-
ium is ingested orally and is transmitted within families
mostly by the mother [3,4]. H. pylori infection is acquired
in childhood and if untreated persists lifelong as a chronic-
ally active infection [5]. Although the majority of infections* Correspondence: A.Michel@dkfz.de
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unless otherwise stated.are asymptomatic, the chronic inflammatory changes of the
gastric mucosa hold the risk for serious diseases of the
gastrointestinal tract. Clinical manifestations begin with
acute gastritis, which in a fraction of cases evolves to
chronic atrophic gastritis. Gastric ulcer develops in 10% of
infected individuals, and gastric adenocarcinoma in 2% and
rarely mucosa-associated lymphoid tissue (MALT) lymph-
oma is induced [6]. It is still under debate if and when to
screen and whom to treat for H. pylori to reach maximum
benefit [7,8]. For development of disease a permanent
gastric inflammatory response to infection appears to be
essential [9] and inflammation is enforced by a complex
interplay of bacterial virulence factors, host cofactors (such
as mediators of inflammation), genetic predispositions
(such as IL-1ß polymorphisms), and dietary factors [10].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Characteristics of the study population (n = 1797)
n (%)
Sex Female 1040 (57.9)
Male 757 (42.1)







H. pylori seropositivity negative (Hp-) 933 (51.9)
positive (Hp+) 864 (48.1)
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changes such as recombination, mutation and uptake
even of exogenous DNA modulate the interaction with
the host and adapt the bacterium to environmental
changes that occur with duration of infection and stage of
disease [10,11]. These interactions with the host might
change the complex immune response with age and might
be reflected in specific antibody patterns which have so far
rarely been investigated in the context of age and gender.
We have recently developed H. pylori multiplex
serology [12]. In contrast to conventional serological
diagnosis of infection, multiplex serology simultan-
eously quantifies antibodies directed against arrays of
protein antigens [13]. Bacterially expressed, affinity-
purified glutathione-S transferase (GST) fusion pro-
teins presenting conformational epitopes [14] are used
as antigens. They are bound to individual sets of fluor-
escent polystyrene beads and antigen-loaded bead mix-
tures are exposed to human serum in a single reaction.
For each bead set, antibodies bound to the respective
antigen are quantified by streptavidin-R-phycoerythrin
labelled monoclonal antibodies to human immuno-
globulin. Multiplex serology allows analysis of 2000
sera per day for antibodies to up to 100 different anti-
gens and thus provides a high-throughput platform for
detection of antibody patterns in large epidemiological
studies.
Using H. pylori multiplex serology [12], we have previ-
ously identified antibodies to HcpC and GroEL as new
independent virulence factors that, in combination with the
established markers anti-CagA and anti-VacA, were highly
predictive of chronic atrophic gastritis risk [15]. We also
found anti-CagA and anti-GroEL to be independent predic-
tors of gastric cancer in a German case–control study [16].
Antibodies to all fifteen H. pylori proteins were associated
with gastric cancer in a Swedish population-based cancer
case–control study [17] and seropositivity to six proteins
(Omp, HP305, HyuA, HpaA, CagA and VacA) may be a
risk marker for distal gastric cancer in the high-incidence
population of China [18].
To characterize the dynamics of the immune response
as reflected in age and gender specific antibody patterns
to fifteen different H. pylori proteins in a healthy popula-
tion, we analysed 1,797 German individuals of a cross-
sectional study representative for the general population
covering the range from 1–82 years of age [19] with H.
pylori multiplex serology.
Results
H. pylori antibody response in the German population
We analysed the antibody response to fifteen H. pylori
proteins, i.e. UreA, GroEL, Catalase, NapA, CagA, CagM,
Cagδ, HP0231, VacA, HpaA, Cad, HyuA, Omp, HcpC and
HP0305 in 1,797 sera of the German population coveringthe range of 1 to 82 years of age (Table 1). Overall H. pylori
seroprevalence (Hp+), defined as antibody reactivity with at
least four H. pylori proteins [12], was 48% (Table 1).
Using predefined cut-off values for classification [12], H.
pylori protein-specific antibody prevalence in all 1,797 sera
was highest for Omp (54%), GroEL (47%) and VacA (46%),
lowest for Cad (15%) and distributed between 25% and 35%
for the other proteins (Table 2).
For each H. pylori protein, antibody prevalence was
significantly higher in Hp+ than in Hp- sera (all P < 0.0001,
Table 2). In Hp+ sera, antibodies to Omp (88%), GroEL
(86%) and VacA (83%) were most prevalent. Antibodies to
Cad (26%) were least prevalent and ranged from 43% to
69% for the other eleven H. pylori proteins. In Hp- sera,
reactions to Omp (23%), UreA (16%), Cag (13%) and VacA
(12%) were most prevalent (Table 2).H. pylori seroprevalence varies by age and gender
Overall H. pylori prevalence was similar for both genders
with 48% in females and 49% in males. Hp + individuals
were significantly older (median: 49 years) than Hp-
individuals (median: 29 years, P < 0.0001). However, the
H. pylori protein-specific seroprevalences depend strongly
on age and gender.
H. pylori seroprevalence and H. pylori protein-specific
prevalences were maximum in the oldest two age groups
and increased significantly per age decade in males and
females for all H. pylori proteins (all P for trend <0.0001,
Figure 1). Overall H. pylori seroprevalence rose more
steeply in males (13.3% per decade) than in females
(10.6%) This corresponds to a mean prevalence increase
per year of 1.2% for both genders. For all H. pylori
proteins, the prevalence increase per age decade was
stronger in males (median: 8.4%, range: 3.8-12.9) than in
females (median: 6.1%, range: 3.4-10.8), even when the
oldest age group was excluded (males median: 7.5%,
range: 2.4-12.7; females median: 6.1%, range: 3.4-11.4).
Table 2 Prevalence of antibodies to H. pylori proteins by HP serostatus
Seroprevalence (%)
Protein Nameb Cut-off [MFI] All (n = 1797) Hp-a (n = 933) Hp+a (n = 864) Pc
HP0547 CagA 3091 33 5 63 < 0.0001
HP0010 GroEL 100 47 10 86 < 0.0001
HP1564 Omp 342 54 23 88 < 0.0001
HP0887 VacA 292 46 12 83 < 0.0001
HP0305 HP0305 100 26 2 52 < 0.0001
HP0410 HpaA 100 25 8 43 < 0.0001
HP0522 Cagδ 107 35 13 60 < 0.0001
HP0695 HyuA 274 27 5 50 < 0.0001
HP1104 Cad 100 15 5 26 < 0.0001
HP0537 CagM 178 30 7 56 < 0.0001
HP0875 Catalase 487 31 9 56 < 0.0001
HP0231 HP0231 100 28 4 53 < 0.0001
HP1098 HcpC 158 34 2 69 < 0.0001
HP0243 NapA 100 27 5 51 < 0.0001
HP0073 UreA 216 33 16 51 < 0.0001
aclassification of H. pylori seropositivity as antibody reactivity with at least 4 antigens; bsee Materials and Methods for protein full names; cFisher’s exact test,
comparison of Hp- and Hp + sera.
Figure 1 H. pylori seroprevalence and antigen-specific seropositivity to 15 different H. pylori proteins in the German population.
Seroprevalence values (%) are given stratified by age group and gender. Stars above columns indicate significant seroprevalence differences
between the corresponding age group and the previous age group within gender (P < 0.05, Fisher’s exact test). H. pylori seroprevalence and all
antigen-specific prevalences increased with age (P for trend < 0.0001, Mantel-Haenszel χ2 test) stronger in males than females.
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lowest for Cad (3.4% in females) (Figure 1).
In the oldest age group, H. pylori seroprevalence and
prevalences for eleven H. pylori proteins (CagA, GroEL,
Omp, VacA, Cagδ, HyuA, CagM, Catalase, HcpC, NapA
and UreA) were significantly higher in males than in
females. This was also observed in the age group 35-44
years for HP0231, HP0305 and Cagδ as well as for UreA
(55-64 years). As the only exception significantly higher
seroprevalence in females was seen for Catalase in the
age group 15-24 years (Figure 1).
Antibody reactivities increase with age among H. pylori
seropositives
Among Hp+ individuals, the antibody responses in-
creased qualitatively and quantitatively with age. H. pylori
protein-specific prevalences increased significantly for
GroEL, HyuA, Cad, CagM, NapA and UreA in both
genders and for Cagδ in females and for VacA and
Catalase in males only (Figure 2). HpaA was the only
antigen showing the opposing effect, a decrease from
the youngest to the age group 54-65 years but this
could be observed in males only (Figure 2).
Reflecting the H. pylori protein-specific prevalence
increases, multiple seropositivity, i.e. the number of anti-
gens recognized also increased with age for both, males
and females (Figure 3). In females, the median numberFigure 2 Qualitative increase of H. pylori antibody responses with age
sera are stratified by age group and gender. Stars above brackets encompa
seroprevalence increases with age within gender (all P for trend <0.05, Manof antigens recognized rose from 7.0 (range 4-12) in the
youngest age group to 9.0 (range 4-15) in the oldest age
group (P = 0.02). While in males, the median started at
8.5 (range 4-13) and rose to 11 (range 5-15) in the oldest
age group. The trend over time did not reach signifi-
cance, but the number of H. pylori proteins recognized
was overall higher in males than females and differed
significantly between gender in the age groups 25-34,
45-54 and 65-82 years (all P < 0.05, Figure 3).
Antibody reactivity to several individual H. pylori pro-
teins also increased with age, for both males and females.
This increase was strongest among the Hp+ sera positive
for GroEL, HyuA, NapA, CagM, Catalase, or UreA. The
median MFI values for these six antigens increased from
the youngest to the oldest age group (Figure 4) in males by
mean 6.1-fold (SD 3.8) and in females by mean 7.2-fold
(SD: 3.6).
Discussion
Previous serological studies describing H. pylori preva-
lence in a general population relied on crude bacterial
lysates as antigens in ELISA. In contrast, our H. pylori
multiplex serology is based on the detection of anti-
bodies to fifteen affinity-purified H. pylori proteins. Def-
inition of H. pylori seropositivity is based on antibody
reactivity with at least four H. pylori proteins. Compared
to a conventional combination of screening ELISA andin H. pylori seropositives (Hp+). Seroprevalence values in Hp+
ssing seroprevalences to a certain H. pylori protein indicate significant
tel-Haenszel χ2 test) or decrease in case of HpaA.
Figure 3 Quantitative increase of H. pylori antibody responses
with age in H. pylori seropositives (Hp+). The median number of
antigens recognized in Hp+ sera is given stratified by age group and
gender. Stars indicate significant differences between genders within the
same age group (P < 0.05, Fisher’s exact test). The difference in the
median number of antigens recognized between the youngest and the
oldest age group is indicated by the horizontal bracket (males: P > 0.05,
females: P = 0.02; Wilcoxon two sample signed rank sum test).
Michel et al. Gut Pathogens 2014, 6:10 Page 5 of 9
http://www.gutpathogens.com/content/6/1/10Western blot confirmation multiplex serology has higher
specificity without loss of sensitivity [12]. A further strength
of multiplex serology is its ability to allow qualitative and
quantitative antibody pattern analysis [16].
The 1573 adult subjects (aged 18–82 years) analysed
here are representative for the non-institutionalized adult
German population [19] concerning age but not gender
distribution since sera were an unbiased subset of a
population-based study conducted between 1985 and
1989 with a female predominance. Children sera were
collected 6 to 17 years later from hospitalised individuals
without gastrointestinal disease and their ability to repre-
sent the general population is therefore limited. We can-
not exclude that the longer storage times and the higher
number of freeze-thaw cycles in the sera from adults
might have reduced antibody reactivities, however the
observed increase from children to adults in number of
antigens recognized and in antibody reactivities against
the individual antigens is opposite to an reducing effect of
longer storage times and more freeze-thaw cycles. The
increases with age among adults were observed in samples
all originating from the same study with same storage and
freeze-thaw cycle history.
We observed an overall H. pylori seroprevalence of 48%,
12% in children <15 years and 52% among adults >25
years. Several population-based studies were conducted in
industrialized countries between 1982 and 1991. In 4,742
subjects from Northern Ireland (12-64 years) [20], and
2237 subjects from San Marino (23- > 70 years) [21] simi-
lar H. pylori prevalences of 50.5% and 51%, respectively,
were reported, in contrast to lower prevalences of 35% in
3589 Danish adults (30-60 years) [22] and 38% in 273
Australian adults (20-80 years) [23].
In comparison to other studies from Germany, we ob-
served 72% of H. pylori prevalence for the group 51-61years which is higher than the 60% reported for 260
healthy adult German blood donors that were younger
and might be healthier than the population analyzed
here [24]. However, the 12% seroprevalence estimated
here in children younger than 14 years is comparable to
the 13% described for 216 children from Germany
before [25].
H. pylori seroprevalence increased strongly with age,
differing by 39% between the groups of 25-34 and 55-
64 years of age. Similar age-specific prevalence estimates
have been described for other developed countries
[20,22,24,26] with the highest prevalence of infection in
the older age groups.
The age-dependent differences in seroprevalence are
either caused by a birth cohort effect [27,28] due to
stronger H. pylori exposure in the past decades or by
cumulating risk of infection with age. The prevalence of
infection depends on the rate of acquisition and loss of
infection. The rate of seroconversion is higher in chil-
dren throughout the world [29-31] although H. pylori
infection can be acquired at all ages [22,32]. The rate of
seroconversion slows down with age in all cohorts
[33,34] to small values of 0.2-1.0% per year estimated as
cross sectional prevalence increase per year in adults of
developed countries [30] which is slightly lower than a
mean prevalence increase of 1.2% per year estimated
here.
The age-dependent increases of seroprevalence were
observed also for all H. pylori proteins reaching maximum
values in males older 65 years. In this oldest age group an
extraordinary steep increase in prevalence occurred for
the majority of proteins in males that we did not observe
in females and that lead to significant gender differences
for eleven of the fifteen proteins. Previous meta-analyses
also highlight a male predominance of H. pylori infection
in 18 publications describing adult populations [35] as a
global phenomenon, but not for children in ten paediatric
populations [36]. In this study none of the proteins
seemed to be associated with young age as a marker of
childhood infection.
The conserved, surface localized lipoprotein H. pylori
adhesion A (HpaA) does not follow the general finding
of a seroprevalence increase by age in H. pylori seroposi-
tives. HpaA seroprevalences significantly decrease with
age in males and at least do not increase in females for
unknown reasons. We performed analyses stratified by
HpaA status (data not shown), and in overall H. pylori
seropositives. Antibodies to HpaA seem to be a marker
for increased immune response, i.e. they are associated
with higher seroprevalence to other H. pylori proteins
and recognition of higher numbers of antigens for both
genders. In contrast, HpaA serostatus does not impact
seroprevalence for other H. pylori proteins in H. pylori
overall seronegatives.
Figure 4 Increase of H. pylori protein-specific antibody reactivities with age. Columns show the median antibody reactivities [MFI] to 15
different H. pylori proteins in Hp + sera also seropositive for the respective antigens stratified by age group and gender. Antibody reactivities to
GroEL, HyuA, NapA, CagM, Catalase and UreA increased from the youngest to the oldest age group with mean of 7.2-fold (SD 3.6) in females and
mean 6.1-fold (SD 3.8) in males.
Michel et al. Gut Pathogens 2014, 6:10 Page 6 of 9
http://www.gutpathogens.com/content/6/1/10The major finding of our study is the observation of a
qualitative increase in the immune response to H. pylori
with age. The degree of multiple seropositivity and strength
of antibody reactivity increased with age among seroposi-
tives for GroEL, HyuA, CagM, Catalase, NapA and UreA.
These proteins are necessary for bacterial colonization and
initiation of the host immune response. GroEL belongs to
the chaperone family and promotes refolding of misfolded
proteins under stress conditions. It seems to be associated
with the adhesion of H. pylori to human gastric epithelial
cells [37] and the induction of inflammatory responses [38].
NapA also mediates the binding of H. pylori to the host cell
[39], activates neutrophils and monocytes and antagonizes
oxidative stress [40]. Catalase is necessary for long term
colonization as part of the antioxidant defence mechanisms
of H. pylori [41]. Survival of H. pylori in the acidic gastric
habitat is secured by its enzyme urease, composed of the
two heterogeneous subunits UreA and UreB, which metab-
olizes urea to carbon dioxide and ammonia [42]. CagM is
necessary for the translocation of the CagA protein into the
host cell via the type IV secretion system [43] and HyuA
belongs to the oxoprolinase family and is important for
aminoacid biosynthesis [44].This cross-sectional study does not allow distinguishing
whether the increase of antibody reactivities is related to
age or birth cohort effect. However our observation that
this phenomenon also occurs in seropositives provides
evidence that it is related to age, and immunosuppression
or lower load of H. pylori infection in younger people as
examples of birth cohort related effects are unlikely. The
increase of antibody reactivities with age is opposed to the
need of H. pylori to escape from the permanent defence of
the innate and adaptive immune response. The niche of the
gastric mucous layer protects H. pylori and makes it
inaccessible to specific antibodies and thereby leaves the
humoral immune response ineffective [9]. The qualitative
increase of antibody reactivities with age might also reflect
higher immunogenicity of bacterial antigens in individ-
uals infected with multiple H. pylori strains which
might be more prevalent in older age groups of the
German population. Colonization with multiple H.
pylori strains is possible [45] and change of strains may
occur during chronic infection [46]. H. pylori adapts its
genome to its host continuously by point mutation, and
intragenomic and intergenomic recombination [8,11].
These mechanisms are discussed to be responsible for
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“individual strain”. So far, H. pylori multiplex serology is
based on antigens conserved among strains and the analysis
of strain multiplicity needs to be addressed in a more
comprehensive evaluation including antigens that allow for
detection of strain specific antibodies.
Conclusion
The ability of H. pylori multiplex serology to simultan-
eously and quantitatively assess antibody responses to
many individual proteins has demonstrated antibody dy-
namics accumulating with age. This most likely reflects
persistent infection and lifelong stimulation of the im-
mune response to H. pylori. These findings might help
to understand the balance between pathogen and host in
asymptomatic individuals and could strengthen future
seroepidemiological case–control studies that may allow
the identification of disease-associated antibody patterns.
Materials and methods
Helicobacter pylori multiplex serology
Detection of antibodies to fifteen H. pylori proteins,
Cad (cinnamyl-alcohol-dehydrogenase ELI3-2), Cagδ
(cag pathogenicity island protein δ), CagM (cag patho-
genicity island protein M), CagA (cytotoxin-associated
antigen A), Catalase, HcpC (conserved hypothetical
secreted protein - paralogue HcpA induces IFNγ),
HP0231 (hypothetical protein HP0231), HP0305 (hypothet-
ical protein HP0305), HpaA (neuraminyllactose-binding
hemagglutinin homolog), HyuA (hydantoin utilization pro-
tein A), GroEL (chaperonin GroEL), NapA (neutrophil acti-
vating protein (bacterioferritin)), Omp (outer membrane
protein), VacA (vacuolating cytotoxin), UreA (urease alpha
subunit) was performed by multiplex serology [12]. The
method is based on a glutathione S-transferase (GST)
capture immunosorbent assay [14,47] in combination with
fluorescent–bead technology as described [13]. Recombinant
H. pylori proteins from strains 26695 and G27 were
expressed in E. coli BL21 Rosetta (Novagen-Merck,
Darmstadt, Germany) as double fusion proteins con-
taining an N-terminal GST domain and a C-terminal
tag peptide derived from the large T antigen of simian
virus 40. The expression constructs have been de-
scribed in detail [12]. Recombinant GST-H. pylori-tag fu-
sion proteins from cleared bacterial lysates were loaded on
spectrally distinct glutathione-casein-coupled fluorescence-
labelled polystyrene beads (SeroMap, Luminex, Austin,
Texas) and affinity-purified in a one-step procedure. Sera
were diluted 1:50 in a serum pre-incubation buffer con-
taining 1 mg/ml casein and 2 mg/ml total lysate protein
from bacteria overexpressing GST-tag without intervening
H. pylori sequences to block binding of antibodies directed
against residual bacterial proteins, GST and the tag pep-
tide. To suppress unspecific binding of antibodies to thebeads themselves, the serum pre-incubation buffer was
supplemented with 0.5% w/v polyvinylalcohol, 0.8% w/v
polyvinylpyrrolidone and 2.5% v/v Superchemiblock
(Millipore, Billerica, MA, USA) [48]. A monoclonal
antibody directed against the C-terminal tag peptide
verified the binding of the GST-H. pylori-tag fusion pro-
teins to the various beads sets [14]. The differently labelled
beads sets loaded with different antigens were mixed and
incubated in 96 well plates with an equal volume of the
serum dilutions. Antibodies bound to the beads via the
GST-H. pylori-tag fusion proteins were stained with
biotinylated goat anti-human IgA, IgM, IgG (Dianova,
Hamburg, Germany) and the reporter conjugate R-
phycoerythrin-labelled streptavidin. A Luminex 100 ana-
lyser identified the internal bead colour and thus the
antigen carried by the bead. The quantity of bound anti-
bodies was determined as the median reporter fluorescence
intensity (MFI) of at least 100 beads per bead set per serum.
Sera
The 1,797 sera used in this study have been described
previously [19,49,50] and contained 1,573 sera from
non-institutionalized donors 18 to 82 years of age (me-
dian: 41.0 years, 651 males) that were a subset (79%) of
the VERA study (“Verbundstudie Ernährungserhebung
und Risikofaktorenanalytik”, n = 1,988), which is a ran-
dom subsample of the “Nationale Verzehrstudie” (NVS),
a population-based nutrition survey (n = 23,209) per-
formed in the West-German population between 1985
and 1989 funded by the Federal Ministry for Research
and Technology. Further sera included were from pa-
tients of university hospitals in Homburg (Germany) in
2002 (n = 175; median age 9, range 2-18; 71 males) and
Heidelberg (Germany) collected in 1991 and 1992 (n =
49; median age 5, range 1-10; 36 males) excluding pa-
tients with gastrointestinal disease. There was no statisti-
cally significant difference in the age structure of the
1,797 serum donors and the German standard popula-
tion (P = 0.70).
For analyses of inter-day and inter-plate variation, a
quality control (QC) panel of 31 previously characterized
[12] sera containing 10H. pylori negative sera (Hp-) and
21H. pylori positive sera (Hp+) were included in the
study.
Assay design, data processing, and cut-off definition
Loading of glutathione-casein coupled bead sets with
their respective antigens was performed in one batch.
The loading efficiency was monitored via detection of
the C-terminal tag of the respective antigens [14]. MFI
values for the different antigens varied less than two-
fold, indicating similar antigen density on the beads.
Correct antigen loading was verified using previously
generated data of the QC panel [12].
Michel et al. Gut Pathogens 2014, 6:10 Page 8 of 9
http://www.gutpathogens.com/content/6/1/10All sera were analysed within three consecutive days,
and the QC panel was included each day. Inter-day vari-
ation was calculated from the three QC data sets of days
1, 2 and 3. Pearson correlation coefficients (R2) for the
individual antigens were calculated from the raw MFI
values and ranged from 0.96 to 0.99 (median: 0.98) for
day 2 versus day 1 and from 0.88 to 0.99 (median: 0.98)
for day 3 versus day 1. To correct for inter-day variation,
the study data of day 2 and day 3 for each antigen were
divided by the slopes of the regression lines of the respective
QC data pairs. Background corrections have been previously
described [12]. For all 15 antigens, antigen-specific cut-off
values were applied that were previously determined
in a validation study [12] from the MFI values of 20
additional sera negative in Helicobacter-R-Biopharm
ELISA as mean plus 3 standard deviations excluding
positive outliers [51]. Study data was normalized to this
previous validation study by dividing the individual antigen
specific antibody reactivity by the slopes of the regression
lines of the QC data pairs of day 1 and the previous
validation study.
Seropositivity for a given protein was defined as anti-
body reactivity greater than the antigen-specific cut-off
(Table 1). H. pylori seropositivity (Hp+) was defined as
seropositivity for at least four proteins as described
previously [12].
Statistical analyses
Statistical significance of differences in continuous vari-
ables, i.e. antibody reactivities (MFI values) and multiple
seropositivity (number of antigens recognized) were ana-
lysed with the Wilcoxon two sample signed rank sum
test. Fisher’s Exact test was used to test for differences in
dichotomous variables, i.e. H. pylori seropositivity and
antibody seroprevalence. Trends in seropositivity with age
were estimated with the Mantel-Haenszel χ2 test on one
degree of freedom. Seroprevalence increases by age were
calculated using linear regression. All tests were performed
two-sided. Analyses were performed with SAS software,
version 9.1 (SAS Institute Inc). Unadjusted seroprevalence
is reported for data stratified by age. P-values below 0.05
were considered statistically significant.
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